首页 | 本学科首页   官方微博 | 高级检索  
检索        

13例体外膜式氧合治疗肺栓塞合并心衰术后应用
引用本文:方艺潭,谷天祥.13例体外膜式氧合治疗肺栓塞合并心衰术后应用[J].中国心血管病研究杂志,2018,16(1).
作者姓名:方艺潭  谷天祥
作者单位:中国医科大学附属第一医院,中国医科大学附属第一医院
摘    要:【】目的:总结成人肺栓塞合并心衰术后应用体外膜式氧合技术(ECMO)治疗的临床经验。方法:2013年12月-2017年6月对我院13例成人肺栓塞合并心衰术后行体外膜式氧合技术治疗,其中,男性8例,女性5例;年龄37-65岁,采用静脉-动脉转流,辅助期间流量范围1.5L/min-3.0L/min,ECMO辅助时间(82.4±47.1)h,维持活化凝血酶时间(ACT)200s-220s结果:13例病人通过应用ECMO治疗过程中没有出现神经系统并发症,患者均成功撤除ECMO,并康复出院。结论:体外膜式氧和技术可以降低肺栓塞取栓术后肺动脉高压、减轻右心负荷、改善气体交换,是治疗肺栓塞术后合并心衰患者的有效手段。

关 键 词:体外膜式氧合  肺动脉栓塞  心衰
收稿时间:2017/7/14 0:00:00
修稿时间:2017/12/1 0:00:00

Clinical management of extracorporeal membrane oxygenation in subacute pulmonary embolism combined heart failure after surgery
gu tianxiang.Clinical management of extracorporeal membrane oxygenation in subacute pulmonary embolism combined heart failure after surgery[J].Chinese Journal of Cardiovascular Review,2018,16(1).
Authors:gu tianxiang
Institution:china medical university attached 1st hospital
Abstract:Objective:To summarize the management experience and result of five adult patients in subacute pulmonary embolism combined heart failure after surgery.Methods :we reviewed the clinical data of 13 patients underwent ECMO from December. 2013 to June. 2017, including 8 male and 5 female aging from 37years old to 65 years old.All of them were used vein-artery perfusion,the perfusion flow varied form 1.5L/min-3.0L/min.During ECMO,their activated clotting time(ACT) was kept 200-220seconds.Results: All of the patients successfully weaned from ECMO.Conclusion : ECMO is an effective mechanical assistant therapy for treating subacute pulmonary embolism combined heart failure after surgery.
Keywords:
点击此处可从《中国心血管病研究杂志》浏览原始摘要信息
点击此处可从《中国心血管病研究杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号